Anti-Human IL13 Recombinant Antibody(Tralokinumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human IL13 Recombinant Antibody(Tralokinumab)

Anti-Human IL13 Recombinant Antibody(Tralokinumab)

产品编号

YR1107

别名

科研级 Tralokinumab ( 曲罗芦单抗 ), Anti-IL13 Recombinant Antibody, Research Grade Tralokinumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Catalog Number	YR1107
Alias	科研级 Tralokinumab ( 曲罗芦单抗 ), Anti-IL13 Recombinant Antibody, Research Grade Tralokinumab
Size	1mg, 5mg
Molecular Name	Tralokinumab
CAS Number	1044515-88-9
Target	IL13[Homo sapiens]
Antibody Isotype	IgG4 Lambda
Clonity	Monoclonal
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Formulation	PBS, pH7.5
Shipping Condition	Shipped on ice packs.
Background	Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, [1] and is designed for the treatment of asthma and other inflammatory diseases.[2] Tralokinumab was discovered by Cambridge Antibody Technology scientists, using Ribosome Display, as CAT-354[3] and taken through pre-clinical and early clinical development.
Application	ELISA, FCM, IP, FuncS, IF, Neut
Remarks	This product is for research use only.

推荐产品

400-621-6806
18630936064（微信同号）
周一至周五 8:30-18:00
0